234 related articles for article (PubMed ID: 30656509)
1. Comparison of the effect of mitomycin C and bevacizumab-methylcellulose mixture on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure (a clinical trial study).
Mostafaei A; Taheri N; Ghojazadeh M; Latifi A; Moghaddam N
Int Ophthalmol; 2019 Oct; 39(10):2341-2351. PubMed ID: 30656509
[TBL] [Abstract][Full Text] [Related]
2. Combined non-penetrating deep sclerectomy with phacoemulsification versus non-penetrating deep sclerectomy alone.
Bilgin G; Karakurt A; Saricaoglu MS
Semin Ophthalmol; 2014 May; 29(3):146-50. PubMed ID: 24506739
[TBL] [Abstract][Full Text] [Related]
3. Deep sclerectomy with bevacizumab and mitomycin C: a comparative study.
Anand N; Bong C
J Glaucoma; 2015 Jan; 24(1):25-31. PubMed ID: 23429630
[TBL] [Abstract][Full Text] [Related]
4. [Short- and medium-term intraocular pressure lowering effects of combined phacoemulsification and non-penetrating deep sclerectomy without scleral implant or antifibrotics].
Moreno-López M; Pérez-Alvarez MJ
Arch Soc Esp Oftalmol; 2006 Feb; 81(2):93-100. PubMed ID: 16511716
[TBL] [Abstract][Full Text] [Related]
5. The EX-PRESS glaucoma shunt versus nonpenetrating deep sclerectomy with Esnoper implant in combined surgery for open-angle glaucoma: a prospective randomized study.
Muñoz M; Anton A; Castany M; Gil A; Martinez A; Muñoz-Negrete FJ; Urcelay J; Moreno-Montañes J
Acta Ophthalmol; 2019 Nov; 97(7):e952-e961. PubMed ID: 30714336
[TBL] [Abstract][Full Text] [Related]
6. Phaco-trabeculotomy combined with deep sclerectomy, a new technique in combined cataract and glaucoma surgery: complication profile.
Lüke C; Dietlein TS; Lüke M; Konen W; Krieglstein GK
Acta Ophthalmol Scand; 2007 Mar; 85(2):143-8. PubMed ID: 17305727
[TBL] [Abstract][Full Text] [Related]
7. Deep sclerectomy in normal-tension glaucoma with and without mitomycin-c.
Suominen S; Harju M; Kurvinen L; Vesti E
Acta Ophthalmol; 2014 Nov; 92(7):701-6. PubMed ID: 24373326
[TBL] [Abstract][Full Text] [Related]
8. Penetrating deep sclerectomy in primary open-angle and pseudoexfoliative glaucoma.
Kozobolis V; Kalogianni E; Sideroudi H
Eur J Ophthalmol; 2020 Mar; 30(2):264-268. PubMed ID: 30773043
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of deep sclerectomy and phacoemulsification and deep sclerectomy in clinical material of Military Health Service Institute--yearly observations.
Marek R; Joanna W; Lewczuk K; Siemiatkowska A; Stankiewicz A
Klin Oczna; 2006; 108(10-12):385-91. PubMed ID: 17455710
[TBL] [Abstract][Full Text] [Related]
10. [Non-penetrating deep sclerectomy in the treatment of advanced cases of open angle glaucoma].
Gierek-Lapińska A; Leszczyński R; Wróbel A
Klin Oczna; 2004; 106(1-2 Suppl):168-9. PubMed ID: 15510486
[TBL] [Abstract][Full Text] [Related]
11. Phacoemulsification-deep sclerectomy modified by trabeculum microperforations and implantation of lens anterior capsule as autologous scleral implant.
Rekas M; Rudowicz J; Lewczuk K; Kluś A; Pawlik B; Stankiewicz A
Curr Med Res Opin; 2010 Aug; 26(8):2025-32. PubMed ID: 20590394
[TBL] [Abstract][Full Text] [Related]
12. Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma.
Kozobolis VP; Christodoulakis EV; Tzanakis N; Zacharopoulos I; Pallikaris IG
J Glaucoma; 2002 Aug; 11(4):287-93. PubMed ID: 12169964
[TBL] [Abstract][Full Text] [Related]
13. Safety and feasibility of the use of a bevacizumab-methylcellulose mixture as an adjunct to glaucoma surgery: a pilot study.
Paula JS; Secches DJ; Silva MJ; Rodrigues Mde L; Cunha Junior Ada S
Arq Bras Oftalmol; 2015; 78(3):194-6. PubMed ID: 26222113
[TBL] [Abstract][Full Text] [Related]
14. Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab Versus Mitomycin C: A Randomized Controlled Trial.
Vahedian Z; Mafi M; Fakhraie G; Zarei R; Eslami Y; Ghadimi H; Mohebbi M
J Glaucoma; 2017 Sep; 26(9):829-834. PubMed ID: 28777224
[TBL] [Abstract][Full Text] [Related]
15. Combined phacoemulsification and deep sclerectomy (PDS) with intraoperative mitomycin C (MMC) augmentation.
Anand S; Anand N
Eye (Lond); 2008 Aug; 22(8):1040-9. PubMed ID: 17464299
[TBL] [Abstract][Full Text] [Related]
16. Nonpenetrating deep sclerectomy with the use of adjunctive mitomycin C.
Neudorfer M; Sadetzki S; Anisimova S; Geyer O
Ophthalmic Surg Lasers Imaging; 2004; 35(1):6-12. PubMed ID: 14750756
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of deep sclerectomy in childhood glaucoma in Saudi Arabia.
Al-Obeidan SA; Osman Eel-D; Dewedar AS; Kestelyn P; Mousa A
Acta Ophthalmol; 2014 Feb; 92(1):65-70. PubMed ID: 23241279
[TBL] [Abstract][Full Text] [Related]
18. Use of a Collagen Matrix Implant as an Adjuvant in Combined Surgery Involving Phacoemulsification and Nonpenetrating Deep Sclerectomy.
Paletta Guedes RA; Gravina DM; Paletta Guedes VM; Chaoubah A
J Glaucoma; 2019 Apr; 28(4):363-366. PubMed ID: 30628996
[TBL] [Abstract][Full Text] [Related]
19. Deep sclerectomy augmented with combination of absorbable biosynthetic sodium hyaluronate scleral implant and mitomycin C or with mitomycin C versus trabeculectomy: long-term results.
Mesci C; Erbil HH; Karakurt Y; Akçakaya AA
Clin Exp Ophthalmol; 2012; 40(4):e197-207. PubMed ID: 21668789
[TBL] [Abstract][Full Text] [Related]
20. Deep Sclerectomy With Mitomycin C and Injectable Cross-linked Hyaluronic Acid Implant: Long-term Results.
Bettin P; Di Matteo F; Rabiolo A; Fiori M; Ciampi C; Bandello F
J Glaucoma; 2016 Jun; 25(6):e625-9. PubMed ID: 26372149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
